SoloVital recalls Umary Acido Hialuronico
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.
- Products
-
- Umary Acido Hialuronico
- Company
- SoloVital
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 1,331 bottles
- About this recall
- Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.